您当前的位置：
首页 >
文章列表页 >
Guizhi Fulingwan in Treatment of Polycystic Ovary Syndrome： A Review
更新时间：2024-09-12

    • Guizhi Fulingwan in Treatment of Polycystic Ovary Syndrome： A Review

      增强出版
    • “Guizhi Fuling Pill has made new progress in the treatment of polycystic ovary syndrome. Research has found that it regulates multiple signaling pathways, improves clinical symptoms, has high safety, and is worth promoting.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 20, Pages: 219-229(2024)

    • DOI：10.13422/j.cnki.syfjx.20240363    

      CLC： R22;G254;R28;R588.6

    • Received：23 October 2023，

      Published Online：17 November 2023，

      Published：20 October 2024

    移动端阅览

  • ZHANG Qianwen,DU Qing,WANG Yue,et al.Guizhi Fulingwan in Treatment of Polycystic Ovary Syndrome： A Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(20):219-229. DOI： 10.13422/j.cnki.syfjx.20240363.

  •  
  •  

0

Views

53

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Determination and Mechanism Prediction of Potential Active Ingredients in Erdongtang Based on UHPLC-QqQ-MS and Network Pharmacology
Progress of Rhei Radix et Rhizoma and Its Combination in Treatment of Cerebral Hemorrhage： A Review
Interpretation of Prescription and Syndrome of Yangjing Zhongyu Tang and Its Modern Research Progress
Herbal Textual Research on Zanthoxylum armatum and Zanthoxyli Radix in Famous Classical Formulas

Related Author

DU Qing
WANG Xueyuan
LI Baoxin
SHI Shougang
HUANG Zhengjun
DAI Yuntao
QIN Xuemei
QI Dahe

Related Institution

Shandong Police Hospital
Modern Research Center for Traditional Chinese Medicine，Shanxi University
Institute of Chinese Materia Medica，China Academy of Chinese Medical Sciences，Beijng
Sunflower Pharmaceutical Group（Xiangyang） Longzhong Co. Ltd.，Xiangyang
Dongzhimen Hospital， Beijing University of Chinese Medicine
0